|
Symbol Name ID |
Alg13
asparagine-linked glycosylation 13 MGI:1914824 |
| Darker colors indicate more annotations |
| Human Phenotypes | Microcephaly |
Delayed CNS myelination |
Abnormal brain morphology |
Abnormal lateral ventricle morphology |
Hydrocephalus |
Cerebral atrophy |
Global brain atrophy |
Clumsiness |
Abnormality of extrapyramidal motor function |
Abnormal pyramidal sign |
Hypsarrhythmia |
Reduced eye contact |
Delayed speech and language development |
Autism |
Self-mutilation |
Cognitive impairment |
Intellectual disability, severe |
Sleep abnormality |
Global developmental delay |
Seizure |
Atonic seizure |
Infantile spasms |
Myoclonic seizure |
Tonic seizure |
| Disease(s) Associated with ALG13 | ||||||||||||||||||||||||
| developmental and epileptic encephalopathy 36 |
| Mouse Phenotypes | increased susceptibility to pharmacologically induced seizures |
environmentally induced seizures |
loss of hippocampal neurons |
astrocytosis |
abnormal synaptic plasticity |
|
| Availability | Mouse Genotype | |||||
| Alg13em1Bayu/Y | ||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 05/07/2024 MGI 6.23 |
|
|
|
||
Analysis Tools